THE INFLUENCE OF THE ROUTE OF ADMINISTRATION ON THE BIOAVAILABILITY OF AN ENDOGENOUS MACROMOLECULE - CHONDROITIN SULFATE (CSA)

被引：16
|
作者：
ANDERMANN, G
DIETZ, M
机构：
来源：
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS | 1982年 / 7卷 / 01期
关键词：
D O I：
10.1007/BF03189537
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：11 / 16
页数：6
相关论文
共 50 条
  • [1] BIOAVAILABILITY OF ORAL CHONDROITIN SULFATE
    LUALDI, P
    RHEUMATOLOGY INTERNATIONAL, 1993, 13 (01) : 39 - 40
  • [2] BIOAVAILABILITY OF ORAL CHONDROITIN SULFATE - REPLY
    BAICI, A
    WAGENHAUSER, FJ
    RHEUMATOLOGY INTERNATIONAL, 1993, 13 (01) : 41 - 43
  • [3] BIOAVAILABILITY ASSESSMENT OF CYCLOSPORINE IN THE RAT - INFLUENCE OF ROUTE OF ADMINISTRATION
    LUKE, DR
    BRUNNER, LJ
    VADIEI, K
    DRUG METABOLISM AND DISPOSITION, 1990, 18 (02) : 158 - 162
  • [4] Influence of route of administration and dosage form in the pharmacokinetics and bioavailability of salbutamol
    R. M. Hernández
    A. R. Gascón
    M. B. Calvo
    C. Caramella
    U. Conte
    A. Domínguez-Gil
    J. L. Pedraz
    European Journal of Drug Metabolism and Pharmacokinetics, 1997, 22 : 145 - 150
  • [5] Influence of route of administration and dosage form in the pharmacokinetics and bioavailability of salbutamol
    Hernandez, RM
    Gascon, AR
    Calvo, MB
    Caramella, C
    Conte, U
    DominguezGil, A
    Pedraz, JL
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1997, 22 (02) : 145 - 150
  • [6] Poly-ion Complex of Chondroitin Sulfate and Spermine and Its Effect on Oral Chondroitin Sulfate Bioavailability
    Ge, Dan
    Higashi, Kyohei
    Ito, Daichi
    Nagano, Kenichi
    Ishikawa, Ryota
    Terui, Yusuke
    Higashi, Kenjirou
    Moribe, Kunikazu
    Linhardt, Robert J.
    Toida, Toshihiko
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2016, 64 (05) : 390 - 398
  • [7] The bioavailability and pharmacokinetics of glucosamine hydrochloride and chondroitin sulfate after oral and intravenous single dose administration in the horse
    Du, JP
    White, N
    Eddington, ND
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2004, 25 (03) : 109 - 116
  • [8] Residual keratan sulfate in chondroitin sulfate formulations for oral administration
    Pomin, Vitor H.
    Piquet, Adriana A.
    Pereira, Mariana S.
    Mourao, Paulo A. S.
    CARBOHYDRATE POLYMERS, 2012, 90 (02) : 839 - 846
  • [9] THE FATE OF THE SULFATE GROUP OF CHONDROITIN SULFATE AFTER ADMINISTRATION TO RATS
    DOHLMAN, CH
    ACTA PHYSIOLOGICA SCANDINAVICA, 1956, 37 (2-3): : 220 - 234
  • [10] Bioavailability of over sulfated chondroitin sulfate. Immunologic implications
    Adiguzel, C.
    Hoppensteadt, D.
    Messmore, H.
    Walenga, J. M.
    Wahi, R.
    Fareed, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 1062 - 1063
12345